Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Letter From The Editor

This week I was talking to a group of physician interns about food choices for diabetes and was trying to explain the value of a low carbohydrate program. During the discussion one of the students interrupted to advise the group that eating less carbohydrates means more fat and that will lead to diabetes, obesity and cholesterol from increased consumption. This led to a discussion about the consumption of carbs and the different types of carbs that are available. Regardless of how much we spoke he was adamant about this.

In light of his misunderstanding this week we have a great article that shows that diets high in carbohydrates boost the concentration of blood glucose and triglycerides which can become problematic at high concentration when they circulate in the blood. In addition a further look into this idea shows that often the things that we think are good are not. A recent study published in Clinical Investigation showed that consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids, and decreases insulin sensitivity in overweight/obese humans.

This really comes into play when we think of how we are yanking soda machines out of schools and replacing them with juice machines. These "healthy drinks" are not really any better as a quick comparison on the website CalorieKing.com shows that 8 ounces of Cola has 27 grams of carbs, while 8 ounces of Apple or grape juice has 28 and 39 grams of carbs respectively. Maybe if more clinicians were open to looking at newer notions we might just be able to make a dent in the metabolic syndrome epidemic.

*****

Announcements:
 
Topics: Joy Pape RN, CDE answers your diabetes questions from the dLife mail; Chef Michel Nischan shows us a modern take on another Italian classic – chicken saltimbocca; Jim Turner and friends talk about diabetes and cravings; Joy Pape RN, CDE educates us on prediabetes. Sundays live online at dLifeTV.com at 7 PM ET, 6 PM CT, and 4 PM PT. Keep up on the latest dLife news at dLifeTV.com.
 
Please answer this week's poll: If the FDA relaxes prescribing restrictions on Avandia, will you recommend it?
 
*****************************
We can make a difference!
*****************************

Dave Joffe, Editor-in-chiefRead More

Scroll down for items in the current newsletter

Newsflash

New Obesity Drug Now Available

Eisai and Arena Pharmaceuticals' obesity drug Belviq is now available in the U.S. Belviq (lorcaserin) is a 5HT2c-receptor agonist that promotes satiety after meals and reduces sensations of hunger before meals.




Tool for your Practice
 
New Guidelines for Type 2 Diabetes in Youth 

Get the new clinical practice guidelines from the American Academy of Pediatrics for the management of type 2 diabetes in children and adolescents. Youth Guidelines Type 2(pdf) 

 

Mobile App of the Week

mySugr

mySugrThe mySugr app which uses the "gamification" concept as well as a sometimes cheeky digital icon to motivate patients is now available in the U.S. for iPhone users. The app helps patients document day-to-day life (like a diabetes diary), provides feedback and keeps them motivated. Points are earned for each entry and patients get the chance to "fight" the defiant diabetes monster. Challenges help to set and pursue some individual goals. Features include: easy and quick logging; smart search; convenient data analysis; neat and clear graphs; photo function; challenges; PDF reports; feedback; secure data backup; and fast multi-device sync. Follow this link for more information.

 

Test Your Knowledge Question #681

Medical nutrition therapy is a step-by-step process. What is the correct order for these steps?….Follow this link for the complete question and answer.

 

Diabetes In Control Has Over 13000 Studies & Articles In Our Archives

Quote of the Week!

"If one advances confidently in the direction of one's dreams, and endeavors to live the life which one has imagined, one will meet with a success unexpected in common hours."

            ...........Henry David Thoreau

 

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidate in the preparation of this week's newsletter:

Jordan Mustonen, 2014 PharmD Candidate, University of Florida College of Pharmacy

 

 
Diabetes In Control Advertisers
 
Cast Your Vote
If the FDA relaxes prescribing restrictions on Avandia, will you recommend it?

Navigate Diabetes In Control
CME/CE of the Week
Jeffrey M. Robbins, DPM

Category: General Diabetes
Credits: .5


Advertisement


Search Articles On Diabetes In Control